Hbox Therapies
Aachen, DE · 1 known investors
Find your way into Hbox Therapies
HBOX Therapies is a medical device company developing the MiRA system, an extracorporeal gas exchange device that oxygenates blood and removes carbon dioxide independently of the lungs as a less invasive alternative to mechanical ventilation. It targets patients with acute respiratory failure in intensive care units, using proprietary technologies including an artificial lung, a hyperbaric gas management system, and a novel blood pump.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Hbox Therapies do?
- HBOX Therapies is a medical device company developing the MiRA system, an extracorporeal gas exchange device that oxygenates blood and removes carbon dioxide independently of the lungs as a less invasive alternative to mechanical ventilation. It targets patients with acute respiratory failure in intensive care units, using proprietary technologies including an artificial lung, a hyperbaric gas management system, and a novel blood pump.
- Who founded Hbox Therapies?
- Hbox Therapies was founded by Niklas Steuer, Peter Schlanstein, Matthias Menne.
- Who are Hbox Therapies's investors?
- Hbox Therapies's investors include TechVision Fonds.
- Where is Hbox Therapies headquartered?
- Hbox Therapies is headquartered in Aachen, DE.